News

We are working to develop our technology and commercialise MSC-based pharmaceuticals – find out more about our day-to-day work.

News

The jury has spoken… and unveiled their list of finalists in the forth edition of Chivas Venture contest designed for startups that are socially ...

Read full

biotechnologia.pl: Poland is among the countries where innovative biopharmaceuticals re being designed to treat household animals. Bioceltix is ...

Read full

We are one of 18 innovative companies taking part in the 5th edition of MIT Enterprise Forum Poland accelerator program. There are three months ...

Read full

proseedmag: the MIT Enterprise Forum Poland program aims to speed up the development of recently-established tech companies. It accomplishes this ...

Read full

 MIT Enterprise Forum Poland, one of the largest accelerator programs in Poland, is part of the  MIT Enterprise Forum network. The program, which ...

Read full

All of the stem-cell-based biopharmaceuticals being developed by our company are designed to treat conditions caused by chronic inflammatory ...

Read full

All hands on deck! Our research and development center is hard at work! Karol Wrzeszcz, our quality control expert, is supervising the job and ...

Read full

The 2nd phase of MIT Enterprise Forum Poland took place at Adamed headquarters on Friday (24 August). During the meeting Paweł Wielgus, a member ...

Read full

The gala that concluded the 8th edition of this ranking took place on June 27th at Warsaw’s Multikino Złote Tarasy. This time the event was ...

Read full

On Friday, August 24th, as part of our involvement in the accelerator program organized by MIT Poland, we are participating in a meeting during ...

Read full

Gazeta Wrocławska: Bioceltix develops biological drugs for common pet diseases. At the moment, the company is working on drugs for locomotor ...

Read full

Scientists, experts and entrepreneurs from Wroclaw have been recognized in the Most Creative Minds in Business Ranking published by Brief ...

Read full

Wrocław scientists in the comfort of laboratories are preparing drugs that change the standards of treating dogs, cats and horses. Just a little ...

Read full

The Jury of the 8th edition of The 50 Most Creative in Business ranking has decided – Łukasz Bzdzion, Bioceltix CEO, took the second place. The ...

Read full

As the first company in Europe, Bioceltix intends to authorize a veterinary biopharmaceutical based on stem cells. Łukasz Bzdzion, the CEO of the ...

Read full

We was on Impact’18, congress that brings leaders at the forefront of innovation from many sectors together to explore the opportunities ...

Read full

CEO of Bioceltix, Łukasz Bzdzion, during the WallStreet conference in Karpacz talked about the AlloMSCs technology, biopharmaceuticals based on ...

Read full

Ranking The 50 Most Creative in Business is an initiative that for 7 years has been helping to build and promote the innovative and creative ...

Read full

– We are the first company in Europe to develop and implement animal-safe and business-scale technology that uses allogeneic stem cells in ...

Read full

To 2020, the participation of biological medicines in the entire pharmaceutical market will increase to nearly 30%. The veterinary market will ...

Read full

Founder and President of Bioceltix is of two natures – the one of an experienced scientist and the one of an entrepreneur, subjecting medical ...

Read full

Between May 25 and 27, the largest Poland-based meeting in of individual investors with entities related to the capital market in Eastern Europe ...

Read full

At the beginning of May, specialists from Bioceltix – jointly with engineers from the Czech-based Block company – conducted functional tests ...

Read full

A stem-cell therapy carried out in the allogeneic setting, standing for one donor-many recipients, enables the manufacture of a batch of the ...

Read full

One of last year’s beneficiaries of Sub-measure 1.1.1 of the Intelligent Development Operational Program 2014-2020 is Bioceltix, a Wroclaw ...

Read full

Our production and quality control facilities are being upgraded to cGMP standards. More equipment designed for quality control of stem ...

Read full

We have concluded a contract with the Czech company BLOCK for a cGMP-compliant modular cell production system for clinical applications, to be ...

Read full

Bioceltix staff visited Spain for almost a week in order to finalise an equipment order for our laboratory. During these few days, we explored ...

Read full

The Bioceltix team is developing its technology, upgrading its workspace to GMP standards and expanding its team. Our specialists were joined by ...

Read full

Bioceltix has selected a supplier of isolated production line equipment. The contract has been awarded to the Czech company – BLOCK. The tender ...

Read full

Our Research and Development Centre and the cGMP-compliant manufacturing facility are located at EIT+, which is one of the most comprehensive ...

Read full

We wouldn’t dare miss the annual “Gospodarcze Otwarcie Roku” (Business Opening of the Year) conference on 21 February 2018. The meeting allows ...

Read full

We are a team is dedicated to the constant search for new biotechnology solutions. We create top-of-the-line stem cell-based pharmaceuticals for ...

Read full

Bioceltix is implementing the project entitled “The production of adipose tissue-derived allogeneic mesenchymal stem cells as compliant with the ...

Read full

Bioceltix is implementing the project entitled “The production of adipose tissue-derived allogeneic mesenchymal stem cells as compliant with the ...

Read full

Wrote about us

(Un)limited stem cells

biotechnologia.pl: Poland is among the countries where innovative biopharmaceuticals re being designed to treat household animals. Bioceltix is developing MSC-based medicines for dogs, horses and cats. The biopharmaceuticals, which are made in Poland, utilise the anti-inflammatory and ...

Article

More startups participating in the MIT Enterprise Forum Poland accelerator program. The technologies they have to offer are full of surprises!

proseedmag: the MIT Enterprise Forum Poland program aims to speed up the development of recently-established tech companies. It accomplishes this by connecting these innovators with the know-how, experience and assets of leading corporations, investment funds as well as various other ...

Article

Bioceltix is entering an infant industry

All of the stem-cell-based biopharmaceuticals being developed by our company are designed to treat conditions caused by chronic inflammatory diseases. We are developing biopharmaceuticals to treat osteoporosis and atopic dermatitis in dogs, chronic inflammation of the oral cavity as well as ...

Article

We know the results of the 50 Most Creative Minds in Business ranking

The gala that concluded the 8th edition of this ranking took place on June 27th at Warsaw’s Multikino Złote Tarasy. This time the event was conducted in an entirely new format. It was hosted by Grzegorz Kiszluk, Editor-in-Chief of Brief Magazine as well as award winners from previous years. ...

Article

Bioceltix – Wroclaw start-up awarded. Creates biological drugs for animals

Gazeta Wrocławska: Bioceltix develops biological drugs for common pet diseases. At the moment, the company is working on drugs for locomotor system diseases (osteoarthritis), autoimmune diseases (atopic dermatitis) and various types of cancer. – The products that we create use the ...

Article